Subscribe To
Warrior sets date for second quarter 2023 earnings announcement and investor conference call
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (“Warrior” or NYSE: HCC) today announced that it will hold its second quarter 2023 invest...
July 17, 2023, 4:45 pm
Agi second quarter 2023 results release date and conference call
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) will hold a confere...
July 17, 2023, 4:35 pm
Gilead's (gild) veklury gets fda nod for label expansion
Gilead's (GILD) antiviral treatment Veklury (remdesivir) has now been approved for the treatment of COVID-19 p...
July 17, 2023, 12:47 pm
Does an “elusive soft landing” spell opportunity for inverse etfs?
Stubborn inflation continues to rack the capital markets and the soft landing that the U.S. Federal Reserve was hoping for in 2023 could prove to be m...
July 17, 2023, 12:35 pm
Gbp/usd: likely to strengthen above 1.3100/05 to retest 1.3145/50 – scotiabank
GBP/USD consolidates as drift from the mid-1.31 area slows. Economists at Scotiabank analyze the pair’s outlook. A bull flag ...
July 17, 2023, 12:14 pm
Tesla sues australia's cap-xx over ev battery technology
Tesla sued Australian company Cap-XX in Texas federal court on Friday, claiming its supercapacitors used for storing energy in electric-vehicle batter...
July 17, 2023, 12:13 pm
Bundesbank: german inflation to cool post sep, but core to stay high
Bundesbank, in its monthly report, anticipates a dip in Germany’s inflation rate starting from Septem...
July 17, 2023, 12:02 pm
Boston scientific (bsx) gets fda nod for vercise software
Boston Scientific's (BSX) Vercise Neural Navigator 5 Software has an improved user interface that presents pat...
July 17, 2023, 12:02 pm
Theseus (thrx) falls 72% on decision to discontinue gist study
Theseus (THRX) announces the discontinuation of enrollment in its phase I/II study of THE-630 in patien...
July 17, 2023, 12:02 pm
Bridgebio pharma stock soars on heart disease drug study results
BridgeBio Pharma Inc shares surged 69% to $30.78 in late-morning trading on Monday after the commercial-stage biopharmaceutical company announced that...
July 17, 2023, 11:33 am
: bridgebio’s stock rockets 66% on news of positive results from late-stage trial of attr-cm treatment
BridgeBio Pharma Inc.’s stock BBIO rocketed 66% in premarket trade Monday, after the company announced positive results in a late-stage trial of a t...
July 17, 2023, 11:32 am
Verizon: shares plunge offering exceptional opportunity (upgrade)
Verizon stock fell sharply after a Wall Street Journal report revealed potential liabilities related to lead-sheathed cables. Weak VZ holders likely b...
July 17, 2023, 11:30 am
patterson cos. (pdco) is a top-ranked value stock: should you buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....
July 17, 2023, 11:18 am
Virios therapeutics announces positive data demonstrating improvement in multiple long-covid symptoms following treatment with a combination of valacyclovir and celecoxib in an exploratory, open-label
ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company fo...
July 17, 2023, 11:05 am
Eli lilly's alzheimer's treatment shows promise in early stages of disease — but safety concerns remain
The Eli Lilly and Co. LLY, -0.47% investigational Alzheimer's treatment donanemab has shown particular promise in treating ...
July 17, 2023, 10:15 am
Lilly drug slows alzheimer's by 60% for mildly impaired patients, alzheimer's group says
Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in th...
July 17, 2023, 10:08 am
Why is bridgebio (bbio) stock up 63% today?
BridgeBio Pharma (NASDAQ: BBIO ) stock is climbing higher on Monday as investors react to results from a Phase 3 clinical trial. These results come f...
July 17, 2023, 10:04 am
Amd: more downside risk than upside potential
The semiconductor industry demand recovery will likely not happen in 2023 as anticipated. Many data poi...
July 17, 2023, 9:52 am
Usdjpy daily analysis – july 17, 2023
The USDJPY pair has made a significant breakthrough by surpassing the resistance level at 138.95, indicating that the recent downtrend from 145.06 has...
July 17, 2023, 9:30 am
Audusd daily analysis – july 17, 2023
The AUDUSD pair has entered a consolidation phase after breaking below the key support level at 0.6845. This suggests a temporary pause in the uptrend...
July 17, 2023, 9:15 am